Recommendations of the panel on cost-effectiveness in health and medicine

Journal of the American Medical Association

Volumn 276, Issue 15, 1996, Pages 1253-1258

  Weinstein, Milton C ^a   Siegel, Joanna E ^a   Gold, Marthe R ^b   Kamlet, Mark S ^c   Russell, Louise B ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Office of Disease Prevention and Health Promotion   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ETHICS; GOVERNMENT; HEALTH; HUMAN; MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; RESEARCH; RESOURCE ALLOCATION; REVIEW;

COST-BENEFIT ANALYSIS; HEALTH CARE RATIONING; HEALTH SERVICES RESEARCH; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 0029794708     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.15.1253     Document Type: Review

References (23)

1. Udvarhelyi S, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med. 1992;116:238-244.
2. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC, for the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996; 276:1172-1177.
3. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
4. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-721.
5. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. In press.
6. Siegel JE, Weinstein MC, Russell LB, Gold MR, for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA. In press.
7. Newhouse JP. Medical care costs: how much welfare loss? J Econ Perspect. 1992;6:3-21.
8. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method for asuring indirect costs of disease. J Health Econ. 1995;14:171-189.
9. Weinstein MC, Stason WB. Hypertension: A Policy Perspective. Cambridge, Mass: Harvard University Press; 1976.
10. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford University Press; 1987.
11. Russell LB. Is Prevention Better Than Cure? Washington, DC: Brookings Institution; 1986.
12. Meltzer DO. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. In press.
13. Torrance GW, Feeny D. Utilities and quality-adjusted life years, Int J Technol Assess Health Care. 1989;5:559-575.
14. Patrick DL, Erickson P. Health Status and Health Policy: Allocating Resources to Health Care. New York, NY: Oxford University Press; 1993.
15. Torrance GW, Boyle MH, Horwood SP. Application of multiattribute utility theory to measure social preferences for health states. Operations Res. 1982;30:1043-1069.
16. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199.
17. . Kapian RM, Andersen JP. A general health policy model: update and applications. Health, Serv Res. 1988;23:203-235.
18. Erickson P, Wilson R, Shannon I. Years of Healthy Life. Hyattsville, Md: Centers for Disease Control and Prevention, National Center for Health Statistics; 1995. Dept of Health and Human Services publication (PHS) 95-1237.
19. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey, I: conceptual framework and item selection. Med Care 1992;30:473-483.
20. Torrance GW. Social preference for health states: an empirical evaluation of three measurement techniques. Socio-economic Plann Sci. 1976; 10:129-136.
21. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes: comparison of assessment methods. Med Decis Making. 1984;4:315-329.
22. Nord E. Methods for quality adjustment of life years. Soc Sci Med. 1992;34:559-569.
23. Krumhoiz HM, Pasternak RC, Weinstein MC, et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med. 1992;327:7-13.